AI News

Follow the latest AI and automation news

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

New benchmark confirms AI video generators look stunning but still can't reason about the world

A new benchmark named WorldReasonBench evaluates video generators based on logical and physical plausibility rather than image quality. ByteDance's Seedance 2.0 leads the pack, outperforming Veo 3.1 and Sora 2, with commercial models scoring about twice as high as open-source alternatives. Logical reasoning remains the most challenging category for all models, highlighting that the transition from pixel generators to actual world models has yet to occur. This gap underscores the disparity between visual quality and logical understanding.

Agents

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

For $1.3 million a month, OpenClaw founder Peter Steinberger runs 100 AI agents that code, review PRs, and find bugs

Peter Steinberger leads a three-person team managing approximately 100 Codex models for the open-source OpenClaw project, resulting in a monthly expenditure of $1.3 million on OpenAI API. Steinberger views these costs as an investment in research, aiming to understand how software evolves when coding expenses are not a barrier. This initiative allows him to explore new possibilities in software development. This experiment is a significant step in understanding AI's impact on software development, potentially transforming how developers operate in the future.

Business

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Strengthening Singapore’s AI Future: A New National Partnership

Google DeepMind has announced a partnership with Singapore to leverage advanced AI in health, education, and sustainability. This collaboration aims to tackle complex challenges, such as enhancing healthcare services and improving educational outcomes. The initiative aligns with Singapore's government efforts to foster technological innovation and address pressing societal issues. By integrating AI solutions, the partnership seeks to create impactful changes in various sectors.

💡

Finding the molecular switches behind new infectious diseases

How might this technology impact future epidemic responses?

Models

Opening new paths in aging research

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Models

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Opening new paths in aging research

Calco Life Sciences has announced the use of its Co-Scientist platform to connect disparate results in aging research. This initiative aims to generate new insights by integrating diverse data, thereby enhancing research effectiveness. It forms part of the company's ongoing efforts to develop innovative solutions in the field of gerontology. Co-Scientist facilitates access to scattered information, enabling researchers to identify patterns and trends that may be obscured in individual datasets. This approach can accelerate the discovery of new treatments and foster collaboration among different research teams.

Models

Accelerating discovery of liver disease mechanisms

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Models

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Accelerating discovery of liver disease mechanisms

Filippo Menolascina is leveraging Co-Scientist to identify new treatments for liver diseases. He highlights that existing drugs only benefit certain patients, underscoring the need for innovative strategies. This initiative marks a significant advancement in personalized medicine for liver conditions. Co-Scientist analyzes genetic and clinical data to pinpoint the most effective treatments. This approach could revolutionize liver disease management by focusing on therapies tailored to individual patient characteristics. Such technology represents a pivotal shift in medical research.

Models

Researchers train AI model that hits near-full performance with just 12.5 percent of its experts

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Models

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Researchers train AI model that hits near-full performance with just 12.5 percent of its experts

Researchers at the Allen Institute for AI and UC Berkeley have developed EMO, a mixture-of-experts model that specializes in content domains rather than word types. This allows for the removal of 75% of the experts while only losing about one percentage point of performance, making MoE models practical for memory-constrained environments. This advancement is significant as it can drastically reduce memory requirements while maintaining high performance. The new model achieves near-full performance using just 12.5% of its experts, opening new avenues for AI applications.

Models

Uniting biological toolkits for a new approach to ALS

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Models

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Uniting biological toolkits for a new approach to ALS

Boston Children’s Hospital has announced a partnership with MIT to explore new RNA-based treatments for Amyotrophic Lateral Sclerosis (ALS). This initiative aims to merge advanced research from both institutions, leveraging modern RNA techniques for innovative therapies. The collaboration represents a significant step in medical research, focusing on improving the quality of life for ALS patients. By combining expertise, they hope to accelerate the development of effective treatments.

Models

Uncovering repurposed medicines to fight liver fibrosis

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Models

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Uncovering repurposed medicines to fight liver fibrosis

A geneticist at Stanford University is utilizing Co-Scientist to explore new treatments for chronic liver diseases and fibrosis. This system enables researchers to analyze genetic data more rapidly, significantly enhancing the potential for discovering effective therapies. This development marks a crucial advancement in personalized medicine, potentially leading to improved patient outcomes. Co-Scientist integrates artificial intelligence with genetic research, providing scientists with advanced tools for data analysis.

Infrastructure

[AINews] Cerebras' $60B IPO: Slowly, then All at Once

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

Infrastructure

16 May 202629 Dhuʻl-Qiʻdah 1447 AH

[AINews] Cerebras' $60B IPO: Slowly, then All at Once

Cerebras has launched its IPO, valuing the company at $60 billion after the offering closed at $280 per share. This follows a significant partnership with OpenAI, reflecting investor confidence in the company's future. Cerebras is viewed as a long-term bet in hardware, having demonstrated its capability with a powerful chip that supports AI models with up to a trillion parameters. CFO Bob Komin stated that Cerebras serves models of all sizes, dispelling rumors about limitations in its capabilities.